Post

Forxiga flunks primary endpoint in DICTATE-AHF trial

At this year’s European Society of Cardiology (ESC) Congress, research found that early initiation of Forxiga (dapagliflozin) failed to improve …

Can steatosis-associated fibrosis estimator scores improve diagnosis of NAFLD/NASH?  

Non-alcoholic fatty liver disease (NAFLD), a result of excess fat buildup in the liver, is one of the most common …

Pain points: Unsolved recruitment and trial design issues in pain clinical trials

Pain is universal, yet it is highly individual and subjective. As such, clinical trials investigating pain face multiple challenges. Even …

Mendus shows early comparability data for its universal cancer vaccine

Mendus has announced that the immune response triggered by vididencel was comparable for patients with acute myeloid leukaemia (AML) and …

SpyBiotech submits CTA to UK MHRA for HCMV vaccine

SpyBiotech has submitted a clinical trial application (CTA) to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the …